
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Phase two trial finds improved survival time among children who have neuroblastoma that comes back or doesn’t respond to usual treatment
- Published: 12 December 2025
Filter
93 results were found based on your search term

Phase two trial finds improved survival time among children who have neuroblastoma that comes back or doesn’t respond to usual treatment

The new recipients of the University’s fellowship scheme will receive support to develop independent research.

Prestigious grants will fund crucial research into gene regulation and antibiotic resistance.

Presentation of data at ESMO Congress 2025 shows MRI scanning before usual diagnostic route sped up time to treatment

Birmingham researchers explored whether long-read whole-genome sequencing could be used to analyse DNA chemistry in urine samples.

Real-time measurement of boron in live cells explains how drugs travel in and out of tumour cells

The test was developed in the University’s bio-incubator, the BioHub Birmingham, and the trials are the culmination of eight years of collaborative research

Cellular work has found mutation in gene that leads to disease progression in myelodysplastic syndromes (MDS)